Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ella Zomer

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Heart, Lung & Circulation|March 21, 2013
Outcomes and excess costs among patients with cardiovascular diseaseZanfina Ademi, Danny Liew, Ella Zomer, et al.
European Journal of Preventive Cardiology|December 12, 2018
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspectiveElla Zomer, Si Si, Thomas R Hird, et al.
Diabetes Research and Clinical Practice|November 8, 2019
Dynamics of switching, adherence, and persistence of dipeptidyl peptidase-4 inhibitors use: A nationwide cohort studyRichard Ofori-Asenso, Jenni Ilomaki, K L Chin, et al.
International Journal of Cardiology|May 13, 2014
Predictors of health care use among patients with or at high risk of atherothrombotic disease: two-year follow-up dataZanfina Ademi, Danny Liew, Alexandra Gorelik, et al.
BMJ Global Health|June 14, 2020
The impact of diabetes on the productivity and economy of BangladeshAfsana Afroz, Thomas R Hird, Ella Zomer, et al.
European Journal of Preventive Cardiology|September 5, 2024
The Reduction of the Productivity Burden of Cardiovascular Disease by Improving the Risk Factor Control Among Australians with Type 2 Diabetes: A 10-Year Dynamic AnalysisDina Abushanab, Daoud Al-Badriyeh, Clara Marquina, et al.
International Journal of Environmental Research and Public Health|November 15, 2018
Effect of Comorbidity Assessed by the Charlson Comorbidity Index on the Length of Stay, Costs and Mortality among Older Adults Hospitalised for Acute StrokeRichard Ofori-Asenso, Ella Zomer, Ken Lee Chin, et al.
European Journal of Preventive Cardiology|August 17, 2021
Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspectiveFeby Savira, Bing H Wang, Andrew R Kompa, et al.
Cardiovascular Diagnosis and Therapy|July 6, 2019
Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndromeRichard Ofori-Asenso, Ella Zomer, Ken Lee Chin, et al.
British Journal of Clinical Pharmacology|November 8, 2018
Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort studyRichard Ofori-Asenso, Jenni Ilomäki, Mark Tacey, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Heart, Lung & Circulation|March 21, 2013
Outcomes and excess costs among patients with cardiovascular diseaseZanfina Ademi, Danny Liew, Ella Zomer, et al.
European Journal of Preventive Cardiology|December 12, 2018
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspectiveElla Zomer, Si Si, Thomas R Hird, et al.
Diabetes Research and Clinical Practice|November 8, 2019
Dynamics of switching, adherence, and persistence of dipeptidyl peptidase-4 inhibitors use: A nationwide cohort studyRichard Ofori-Asenso, Jenni Ilomaki, K L Chin, et al.
International Journal of Cardiology|May 13, 2014
Predictors of health care use among patients with or at high risk of atherothrombotic disease: two-year follow-up dataZanfina Ademi, Danny Liew, Alexandra Gorelik, et al.
BMJ Global Health|June 14, 2020
The impact of diabetes on the productivity and economy of BangladeshAfsana Afroz, Thomas R Hird, Ella Zomer, et al.
European Journal of Preventive Cardiology|September 5, 2024
The Reduction of the Productivity Burden of Cardiovascular Disease by Improving the Risk Factor Control Among Australians with Type 2 Diabetes: A 10-Year Dynamic AnalysisDina Abushanab, Daoud Al-Badriyeh, Clara Marquina, et al.
International Journal of Environmental Research and Public Health|November 15, 2018
Effect of Comorbidity Assessed by the Charlson Comorbidity Index on the Length of Stay, Costs and Mortality among Older Adults Hospitalised for Acute StrokeRichard Ofori-Asenso, Ella Zomer, Ken Lee Chin, et al.
European Journal of Preventive Cardiology|August 17, 2021
Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspectiveFeby Savira, Bing H Wang, Andrew R Kompa, et al.
Cardiovascular Diagnosis and Therapy|July 6, 2019
Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndromeRichard Ofori-Asenso, Ella Zomer, Ken Lee Chin, et al.
British Journal of Clinical Pharmacology|November 8, 2018
Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort studyRichard Ofori-Asenso, Jenni Ilomäki, Mark Tacey, et al.
Pageof 12